A Phase 2 Clinical Trial of Combination Nivolumab, Ipilimumab, and Paclitaxel in Patients With Untreated Metastatic NSCLC: The OPTIMAL Trial

Authors: Clarke, Jeffrey M., Gu, Lin, Wang, Xiaofei F., Stinchcombe, Thomas E., Stevenson, Marvaretta M., Ramalingam, Sundhar, Shariff, Afreen, Garst, Jennifer, Nixon, Andrew B., Antonia, Scott J., Crawford, Jeffrey, Ready, Neal E.

Source: In JTO Clinical and Research Reports June 2022 3(6)

Atezolizumab Before and After Chemoradiation for Unresectable Stage III Non–Small Cell Lung Cancer: A Phase II Nonrandomized Controlled Trial.

Authors: Ross, Helen J., Kozono, David, Wang, Xiaofei F., Urbanic, James John, Williams, Terence M., Nelson, Garth D., Carbone, David P., Chung, Dongjun, Robb, Ryan, Byun, Woo Yul, Talabere, Tiffany, DuFrane, Carter, Bara, Ilze, Schulze, Katja, Brockman, Michelle, Gao, Junheng, Vokes, Everett E., Stinchcombe, Thomas E.

Source: JAMA Oncology; Sep2024, Vol. 10 Issue 9, p1212-1219, 8p

Maintenance Sunitinib following Initial Platinum-Based Combination Chemotherapy in Advanced-Stage IIIB/IV Non–Small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study—CALGB 30607 (Alliance)

Authors: Baggstrom, Maria Q., Socinski, Mark A., Wang, Xiaofei F., Gu, Lin, Stinchcombe, Thomas E., Edelman, Martin J., Baker, Sherman, Jr., Feliciano, Josephine, Novotny, Paul, Hahn, Olwen, Crawford, Jeffrey A., Vokes, Everett E.

Source: In Journal of Thoracic Oncology May 2017 12(5):843-849

Long-term Survival After Surgery Compared With Concurrent Chemoradiation for Node-negative Small Cell Lung Cancer

Authors: Yang, Chi-Fu Jeffrey, Chan, Derek Y., Shah, Shivani A., Yerokun, Babatunde A., Wang, Xiaofei F., D'Amico, Thomas A., Berry, Mark F., Jr, David H. Harpole

Source: Annals of surgery. 268(6):1105-1112

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100178194625.0x000001&indx=1&recIds=ETOCvdc_100178194625.0x000001

Multitrial Evaluation of Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Extensive-Stage Small-Cell Lung Cancer

Authors: Foster, Nathan R., Renfro, Lindsay A., Schild, Steven E., Redman, Mary W., Wang, Xiaofei F., Dahlberg, Suzanne E., Ding, Keyue, Bradbury, Penelope A., Ramalingam, Suresh S., Gandara, David R., Shibata, Taro, Saijo, Nagahiro, Vokes, Everett E., Adjei, Alex A., Mandrekar, Sumithra J.

Source: In Journal of Thoracic Oncology July 2015 10(7):1099-1106

Detection of human telomerase reverse transcriptase mRNA in cells obtained by lavage of the pleura is not associated with worse outcome in patients with stage I/II non–small cell lung cancer: Results from Cancer and Leukemia Group B 159902

Authors: Boylan, Alice M., Wang, Xiaofei F., Ko, Richard, Watson, Patricia M., Gu, Lin, Harpole, David, Bueno, Raphael, Kelly, Rosemary, Kohman, Leslie, Kratzke, Robert

Source: In The Journal of Thoracic and Cardiovascular Surgery July 2013 146(1):206-211

Intraoperative Sentinel Node Mapping with Technitium-99 in Lung Cancer: Results of CALGB 140203 Multicenter Phase II Trial

Authors: Liptay, Michael J., D'amico, Thomas A., Nwogu, Chumy, Demmy, Todd L., Wang, Xiaofei F., Gu, Lin, Litle, Virginia R., Swanson, Scott J., Kohman, Leslie J.

Source: In Journal of Thoracic Oncology February 2009 4(2):198-202

Phase II Randomized Study of Dose-Dense Docetaxel and Cisplatin Every 2 Weeks With Pegfilgrastim and Darbepoetin Alfa With and Without the Chemoprotector BNP7787 in Patients With Advanced Non-small Cell Lung Cancer (CALGB 30303)

Authors: Miller, Antonius A., Wang, Xiaofei F., Gu, Lin, Hoffman, Philip, Khatri, Jamil, Dunphy, Frank, Edelman, Martin J., Bolger, Michael, Vokes, Everett E., Green, Mark R.

Source: In Journal of Thoracic Oncology October 2008 3(10):1159-1165

Phase II Trial of Paclitaxel–Topotecan–Etoposide Followed by Consolidation Chemoradiotherapy for Limited-Stage Small Cell Lung Cancer: CALGB 30002

Authors: Miller, Antonius A., Wang, Xiaofei F., Bogart, Jeffrey A., Hodgson, Lydia D., Lima, Caio M. S. Rocha, Radford, James E., Vokes, Everett E., Green, Mark R.

Source: In Journal of Thoracic Oncology July 2007 2(7):645-651

AFT-16: Phase II trial of neoadjuvant and adjuvant atezolizumab and chemoradiation (CRT) for stage III non-small cell lung cancer (NSCLC).

Authors: Ross, Helen J., Kozono, David E., Urbanic, James John, Williams, Terence Marques, DuFrane, Carter, Bara, Ilze, Schulze, Katja, Brockman, Jane Michelle, Wang, Xiaofei F., Gao, Junheng, Vokes, Everett E., Stinchcombe, Tom

Source: Journal of clinical oncology. 39(15 suppl):8513-8513

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100173217685.0x000001&indx=1&recIds=ETOCvdc_100173217685.0x000001

Phase 3 comparison of high-dose once-daily (QD) thoracic radiotherapy (TRT) with standard twice-daily (BID) TRT in limited stage small cell lung cancer (LSCLC): CALGB 30610 (Alliance)/RTOG 0538.

Authors: Bogart, Jeffrey A, Wang, Xiaofei F., Masters, Gregory A., Gao, Junheng, Komaki, Ritsuko, Kuzma, Charles S., Heymach, John, Petty, William J., Gaspar, Laurie E., Waqar, Saiama Naheed, Stinchcombe, Tom, Bradley, Jeffrey D., Vokes, Everett E.

Source: Journal of clinical oncology. 39(15 suppl):8505-8505

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100173217593.0x000001&indx=1&recIds=ETOCvdc_100173217593.0x000001

Neoadjuvant immunotherapy in sarcomatoid mesothelioma (Alliance A082101).

Authors: Mansfield, Aaron Scott, Wang, Xiaofei F., Wigle, Dennis A., Watt, Colleen, Masters, Gregory A., Kelley, Kathryn, Kozono, David E., Stinchcombe, Tom

Source: Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, pTPS8602-TPS8602, 1p

A phase 1 first-in-human study of interferon beta (IFNβ) and membrane-stable CD40L expressing oncolytic virus (MEM-288) in solid tumors including non–small-cell lung cancer (NSCLC).

Authors: Saltos, Andreas Nicholas, Arrowood, Christy, Beasley, Georgia, Ronald, James, El-Haddad, Ghassan, Guerra-Guevara, Luiziane, Khan, Uzma, Wolf, Steven, Gu, Lin, Wang, Xiaofei F., Foresman, Dana, Yu, Xiaoqing, Cantwell, Mark J., Antonia, Scott Joseph, Beg, Amer A, Ready, Neal E.

Source: Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, p2569-2569, 1p

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

D5-01: Prognostic significance of molecular markers and clinical factors in stage ib non-small cell lung cancer (NSCLC): a laboratory companion study to CALGB 9633

Authors: Graziano, Stephen L., Gu, Lin, Wang, Xiaofei F., Tatum, Arthur H., Vollmer, Robin T., Strauss, Gary M., Kratzke, Robert A., Green, Mark R., Vokes, Everett E.

Source: In Journal of Thoracic Oncology August 2007 2(8) Supplement:S403-S403